tradmap

BMRA BIOMERICA INC

$1.88 -4.34%

Healthcare · In Vitro & In Vivo Diagnostic Substances

BIOMERICA INC (BMRA) is a healthcare company in the In Vitro & In Vivo Diagnostic Substances industry, with a market capitalization of $6 million. Shares last traded at $1.88, 64.2% below their 52-week high. Over the past year the stock is down 46.0%. Net profit margin is -93.6%, below the peer median of -3.8%. Revenue declined 1.9% year over year.

Market Cap
$6M
Shares Out
3.1M
EPS (TTM)
$-2.87
P/E Ratio
P/S Ratio
1.09
P/B Ratio
1.75
Dividend / Share
Dividend Yield
52-Week High
$5.24
52-Week Low
$1.87
Volume
320
Avg Vol (3m)
1,087.841

Performance

1W
-10.93%
1M
-22.20%
3M
-9.86%
6M
-17.04%
YTD
-25.89%
1Y
-45.97%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
29.59
SMA (50)
$2.19
SMA (200)
$2.53
Price vs SMA50
-14.35%
Price vs SMA200
-25.78%
ATR (14)
$0.07

Financials

Revenue
$5M
Net Income
$-5M
Gross Margin
9.4%
Operating Margin
-96.7%
Net Margin
-93.6%
Return on Equity
-149.9%
Return on Assets
-101.9%
Current Ratio
2.64
Debt / Equity
0.47
Revenue Growth (YoY)
-1.9%

Latest reported annual period ending 2025-05-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 $-0.92 2026-04-13
Q2 2026 $-0.48 2026-01-14
Q1 2026 $0.00 2025-10-14
FY 2025 $-2.16 2025-08-29
Q3 2026 $-1.47 2026-04-13
Q2 2026 $-0.13 2026-01-14

Full earnings history →

In Vitro & In Vivo Diagnostic Substances peers

BMRA vs 14 industry peers (In Vitro & In Vivo Diagnostic Substances), by market cap.

P/S vs peers
1.09 / 4.39 med
-75% discount
Net margin vs peers
-93.6% / -3.8% med
below median
1–14 of 14
IDXXIdexx Laboratories$44.3B41.8410.3024.6%+2.91%
LNTHLantheus Holdings, Inc.$6.8B28.974.3915.2%+0.67%
CLDXCelldex Therapeutics, Inc.$2.5B-9.84-1.47%
NTLAIntellia Therapeutics, Inc.$2.2B-5.30+2.25%
NEOGNeogen Corp$2.0B-1.85+4.14%
QDELQuidelortho Corp$932M+4.27%
ACHVAchieve Life Sciences, Inc.$496M-9.07-9.72%
MYGNMyriad Genetics Inc$429M-1.170.52-44.4%+3.65%
TKNOAlpha Teknova, Inc.$282M-16.326.95-42.6%+6.38%
IMDXInsight Molecular Diagnostics Inc.$176M-3510.5043.48-1.2%+2.25%
ICCCIMMUCELL CORP /DE/$86M-82.253.09-3.8%+0.53%
QCLSQ/C TECHNOLOGIES, INC.$32M-2.72+4.28%
VNRXVOLITIONRX LTD$12M-0.52+6.14%
CDIOCardio Diagnostics Holdings, Inc.$6M+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.